• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过分子动力学模拟和分子对接揭示 HDAC1 的结构特征及其选择性抑制作用的研究进展。

Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking.

机构信息

a Laboratorio de Modelado Molecular, Bioinformática y Diseño de fármacos, Sección de Estudios de Posgrado e Investigación , Escuela Superior de Medicina, Instituto Politécnico Nacional , Mexico City 11340 , Mexico.

出版信息

J Biomol Struct Dyn. 2019 Feb;37(3):584-610. doi: 10.1080/07391102.2018.1441072. Epub 2018 Mar 6.

DOI:10.1080/07391102.2018.1441072
PMID:29447615
Abstract

Histone deacetylases (HDACs) are a family of proteins whose main function is the removal of acetyl groups from lysine residues located on histone and non-histone substrates, which regulates gene transcription and other activities in cells. HDAC1 dysfunction has been implicated in cancer development and progression; thus, its inhibition has emerged as a new therapeutic strategy. Two additional metal binding sites (Site 1 and Site 2) in HDACs have been described that are primarily occupied by potassium ions, suggesting a possible structural role that affects HDAC activity. In this work, we explored the structural role of potassium ions in Site 1 and Site 2 and how they affect the interactions of compounds with high affinities for HDAC1 (AC1OCG0B, Chlamydocin, Dacinostat and Quisinostat) and SAHA (a pan-inhibitor) using molecular docking and molecular dynamics (MD) simulations in concert with a Molecular-Mechanics-Generalized-Born-Surface-Area (MMGBSA) approach. Four models were generated: one with a potassium ion (K) in both sites (HDAC1), a second with K only at site 1 (HDAC1), a third with K only at site 2 (HDAC1) and a fourth with no K (HDAC1). We found that the presence or absence of K not only impacted the structural flexibility of HDAC1, but also its molecular recognition, consistent with experimental findings. These results could therefore be useful for further structure-based drug design studies addressing new HDAC1 inhibitors.

摘要

组蛋白去乙酰化酶(HDACs)是一类蛋白质,其主要功能是从位于组蛋白和非组蛋白底物上的赖氨酸残基上去除乙酰基,从而调节细胞中的基因转录和其他活动。HDAC1 功能障碍与癌症的发生和发展有关;因此,其抑制作用已成为一种新的治疗策略。已经描述了 HDACs 中的另外两个金属结合位点(Site 1 和 Site 2),主要由钾离子占据,表明其可能具有影响 HDAC 活性的结构作用。在这项工作中,我们通过分子对接和分子动力学(MD)模拟,结合分子力学广义 Born 表面面积(MMGBSA)方法,研究了钾离子在 Site 1 和 Site 2 中的结构作用,以及它们如何影响与 HDAC1 具有高亲和力的化合物(AC1OCG0B、Chlamydocin、Dacinostat 和 Quisinostat)和 SAHA(pan-inhibitor)的相互作用。生成了四个模型:一个在两个位点(HDAC1)都有钾离子(K),一个只有 Site 1 有 K(HDAC1),一个只有 Site 2 有 K(HDAC1),一个没有 K(HDAC1)。我们发现,K 的存在与否不仅影响 HDAC1 的结构灵活性,还影响其分子识别,这与实验结果一致。因此,这些结果可能有助于进一步开展基于结构的药物设计研究,以开发新的 HDAC1 抑制剂。

相似文献

1
Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking.通过分子动力学模拟和分子对接揭示 HDAC1 的结构特征及其选择性抑制作用的研究进展。
J Biomol Struct Dyn. 2019 Feb;37(3):584-610. doi: 10.1080/07391102.2018.1441072. Epub 2018 Mar 6.
2
A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.一种利用药效团建模、3D-QSAR分析、分子对接、密度泛函和分子动力学模拟研究来探索新型HDAC1抑制剂的机制方法。
J Mol Graph Model. 2016 Nov;70:54-69. doi: 10.1016/j.jmgm.2016.09.008. Epub 2016 Sep 14.
3
Identification of Hydroxamic Acid Based Selective HDAC1 Inhibitors: Computer Aided Drug Design Studies.基于异羟肟酸的选择性HDAC1抑制剂的鉴定:计算机辅助药物设计研究
Curr Comput Aided Drug Des. 2019;15(2):145-166. doi: 10.2174/1573409914666180502113135.
4
In silico approaches for investigating the binding propensity of apigenin and luteolin against class I HDAC isoforms.基于计算机的方法研究芹菜素和木樨草素与 I 类组蛋白去乙酰化酶同工型的结合倾向。
Future Med Chem. 2018 Aug 1;10(16):1925-1945. doi: 10.4155/fmc-2018-0020. Epub 2018 Jul 11.
5
Fragment-Based Drug Design of Selective HDAC6 Inhibitors.选择性组蛋白去乙酰化酶6(HDAC6)抑制剂的基于片段的药物设计
Methods Mol Biol. 2021;2266:155-170. doi: 10.1007/978-1-0716-1209-5_9.
6
Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach.采用 MMGBSA 方法探索丙戊酸对组蛋白去乙酰化酶家族的抑制活性。
J Comput Aided Mol Des. 2020 Aug;34(8):857-878. doi: 10.1007/s10822-020-00304-2. Epub 2020 Mar 16.
7
Structural Requirements of Histone Deacetylase Inhibitors: SAHA Analogs Modified on the Hydroxamic Acid.组蛋白去乙酰化酶抑制剂的结构要求:基于异羟肟酸修饰的SAHA类似物
Arch Pharm (Weinheim). 2016 May;349(5):373-82. doi: 10.1002/ardp.201500472. Epub 2016 Apr 9.
8
Identification of structural fingerprints among natural inhibitors of HDAC1 to accelerate nature-inspired drug discovery in cancer epigenetics.鉴定 HDAC1 的天然抑制剂中的结构指纹,以加速癌症表观遗传学中的基于自然的药物发现。
J Biomol Struct Dyn. 2024 Jul;42(11):5642-5656. doi: 10.1080/07391102.2023.2227710. Epub 2023 Jun 26.
9
Investigation on the isoform selectivity of histone deacetylase inhibitors using chemical feature based pharmacophore and docking approaches.基于化学特征药效团和对接方法研究组蛋白去乙酰化酶抑制剂的同工型选择性。
Eur J Med Chem. 2010 May;45(5):1777-91. doi: 10.1016/j.ejmech.2010.01.010. Epub 2010 Jan 28.
10
A comparative study based on docking and molecular dynamics simulations over HDAC-tubulin dual inhibitors.基于对接和分子动力学模拟的HDAC-微管蛋白双重抑制剂的比较研究。
J Mol Graph Model. 2016 Nov;70:170-180. doi: 10.1016/j.jmgm.2016.10.007. Epub 2016 Oct 7.

引用本文的文献

1
Discovery and Exploration of Small Molecule Binders for CT83: Computational Insights from Homology Modeling, Virtual Screening, MD Simulations, Interaction Fingerprint, and Network Communications.CT83小分子结合剂的发现与探索:来自同源建模、虚拟筛选、分子动力学模拟、相互作用指纹图谱和网络通讯的计算见解
ACS Omega. 2025 May 23;10(22):22884-22908. doi: 10.1021/acsomega.5c00053. eCollection 2025 Jun 10.
2
Alchemical approach performance in calculating the ligand-binding free energy.炼金术方法在计算配体结合自由能方面的性能。
RSC Adv. 2024 May 8;14(21):14875-14885. doi: 10.1039/d4ra00692e. eCollection 2024 May 2.
3
A Review on Molecular Docking on HDAC Isoforms: Novel Tool for Designing Selective Inhibitors.
组蛋白去乙酰化酶亚型的分子对接研究综述:设计选择性抑制剂的新工具
Pharmaceuticals (Basel). 2023 Nov 22;16(12):1639. doi: 10.3390/ph16121639.
4
Distinct biochemical properties of the class I histone deacetylase complexes.I 类组蛋白去乙酰化酶复合物的独特生化特性。
Curr Opin Chem Biol. 2022 Oct;70:102179. doi: 10.1016/j.cbpa.2022.102179. Epub 2022 Jul 6.
5
Interaction and Inhibition of a Proteoglycan on PTP1B Activity for Anti-diabetes.一种蛋白聚糖对蛋白酪氨酸磷酸酶1B活性的相互作用及抑制作用在抗糖尿病中的应用
ACS Omega. 2021 Oct 27;6(44):29804-29813. doi: 10.1021/acsomega.1c04244. eCollection 2021 Nov 9.
6
Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs).基于结构的 I 类组蛋白去乙酰化酶(HDACs)抑制剂发现。
Int J Mol Sci. 2020 Nov 22;21(22):8828. doi: 10.3390/ijms21228828.
7
Computer-Driven Development of an in Silico Tool for Finding Selective Histone Deacetylase 1 Inhibitors.计算机驱动的寻找选择性组蛋白去乙酰化酶 1 抑制剂的计算工具的开发。
Molecules. 2020 Apr 22;25(8):1952. doi: 10.3390/molecules25081952.
8
Molecular Neuroprotection Induced by Zinc-Dependent Expression of Hepatitis C-Derived Protein NS5A Targeting Kv2.1 Potassium Channels.锌依赖的丙型肝炎病毒 NS5A 蛋白表达诱导的分子神经保护作用:靶向 Kv2.1 钾通道。
J Pharmacol Exp Ther. 2018 Nov;367(2):348-355. doi: 10.1124/jpet.118.252338. Epub 2018 Sep 6.